Navigation Links
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
Date:9/10/2009

SAN DIEGO and BANGALORE, India, Sept. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology. A phybrid is a peptide hybrid molecule that combines the pharmacological effects of two peptide hormones into a single molecular entity.

Under the terms of the Development and Commercialization Agreement, Amylin will provide expertise in peptide hormone development, particularly in the area of phybrid technology, as well as metabolic disease therapeutics. Biocon will utilize its expertise in recombinant microbial expression to manufacture the compound and also leverage its experience in preclinical and clinical development of diabetes products.

"This agreement fully leverages the synergistic capabilities of the two companies," said Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon, Ltd. "Amylin's knowledge of peptide therapeutics and their leadership in the diabetes market, paired with Biocon's capabilities in process development, manufacturing and clinical development, provides this global program with the potential to effectively bring a novel therapy to patients living with diabetes."

"This program could unleash the potential of cutting-edge peptide science to transform the lives of patients with diabetes," said Daniel M. Bradbury, President and Chief Executive Officer, Amylin Pharmaceuticals. "We are pleased to work with Biocon, a biologics
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals Reports Second Quarter Financial Results
2. Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009
3. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
4. Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
5. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
6. Amylin Issues Statement Regarding Open Letter From Icahn
7. Icahn Issues Open Letter to Amylin Shareholders
8. Amylin Sends Letter to Shareholders
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
11. Amylin Pharmaceuticals to Webcast First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...PPYneuron,s most popular and addictive game, Split...ch. , Mountain View, CA (...ular and addictive game, SplitWords, is now availa...esigned to help banish that ,tip of the tongue, sy...game challenges the brain by encouraging users to...
(Date:11/20/2009)...ov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceut... of Shareholders will be held on Monday, December ...r approval of two special resolutions. The first s...sale of all or substantially all of the assets of ...n the asset purchase agreement dated November 10, ...
(Date:11/20/2009)... Nov. 20 Rates of infect...ed in late October, but the pandemic flu virus con...age groups, including the elderly, according to a ...: DGX ), the world,s leading provider of diagnos...ts most recent Quest Diagnostics Health Trends(TM)...
(Date:11/20/2009)... The following is a sta... Nevada Health Care Association: ,, "The Nevada...s Senate Majority Leader Harry Reid for his leader... goal of protecting every Nevada seniors, ongoing ...g the strength and viability of our state,s vital ...
(Date:11/20/2009)...mber 20, 2009Emergency medical service (EMS) provi...000 cardiac arrests each year. Only 5 to 10 perce...e. Better quality cardiopulmonary resuscitation (...associated with better patient outcome. The Resus...clinical research network to study prehospital tre...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
... from Film to IDC Digital ...rstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TS...market for,digital radiography, today announced th... conventional film X-ray,equipment in its three ra...
...l Inc. urges Americans to use the...N.J., April 7, 2008 At the local drug,store, do y..." Convinced,there,s nothing you can do to improve ...cans to be proactive about their,genetic legacy. B...
... is caused by mutations that allow defective bloo...To devise effective therapies it is crucial to kno...ype gives rise to leukaemic cells. Researchers fro... Lund, Sweden, have now used genetic engineering t...
...nia,Secretary of Health Dr. Calvin B. Johnson kick...burg by urging United Way executives to help chang... week, we will be meeting with those who are worki...nsylvania,because people without insurance are mor...
... overweight by 50%, study concludes, , , M...rve healthier foods, offer nutrition education and...make a major difference in preventing childhood ob...dren by 50 percent, the study, published in the Ap...
...r,Medical Technologies, Inc. (Pink Sheets: RBRM), ...unced that the corporation is ready to grow into,o...public equity markets., (Logo: http://www.newsco...nly on the Pink Sheets with a large number,of shar...
Other Medicine News:Health News:Saratoga Hospital Purchases Three IDC DR Systems 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 3Health News:Know Your Personal Genetic Health to Age Better Now! 2Health News:An unexpected way to cause leukemia 2Health News:Pennsylvania Health Secretary Focuses on Changing the Climate of Health Care During National Public Health Week 2Health News:School Environment Can Curb Kids' Weight Gain 2Health News:ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - 'NASDAQ, here we come!' 2
(Date:11/20/2009)...-- The United States Court of Appeals for the Fir... yesterday, approving a settlement in the long-run...litigation against AstraZeneca Pharmaceuticals ( A...prnh/20080317/AQM144LOGO ) ,, The ruling affirm...d the pharmaceutical giant,s prostate cancer drug ...
(Date:11/20/2009)...irstCall/ -- Medco Health Solutions, Inc (NYSE: ... American healthcare through an advanced, wired ph...quality clinical care and fundamentally bending th...or the benefit of patients and payors alike. ,,...ts strategy enable "Smarter Medicine" to help addr...
(Date:11/20/2009)...re/ -- ,, Reportlinker.com announces that a ne...ogue. ,, India Medical Equipment Market Analys...tlinker.com/p0164658/India-Medical-Equipment-Marke...rnewswire&utm_medium=pr&utm_campaign=prnew...uipment Market Analysis and Forecasts to 2015 ,...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13FREE Wash Your Hands Song from Edutunes com Teaches Children How to Stay Healthy 47694 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 47690 1A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 47690 2
...inical Results Expected in November 2008, BOTHELL...announced today the completion of patient enrollme...rials to evaluate the safety and,efficacy of its f...fen for,the over-the-counter (OTC) market. The Com...pivotal trial in November 2008. Ibuprofen is an an...
...May Someday Inform Treatments for Spinal Cord, Oth...ein that enables,nerve cells to communicate with e...loping nervous system. Research into how that prot...cells may provide a basis for eventual,treatments ...system,including spinal cord injury., "This expan...
Other Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3
Codmans Micro Osseous Dissection Curette
Karlin XL Magnum Cup Curette
Caspar
Kerpel
Medicine Products: